Form 4 for HOWL Werewolf Therapeutics, Inc.
Accepted 2022-01-14 00:00:00 ET · period of report 2022-01-06 · accession 0000899243-22-002027 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-01-14 | 2022-01-12 | HOWL | Seidel-Dugan Cynthia | CSO | M - OptEx | $2.81 | +39.7K | 149.4K | +36% | +$111.8K |
| DM | 2022-01-14 | 2022-01-12 | HOWL | Seidel-Dugan Cynthia | CSO | M - OptEx | $0.00 | -39.7K | 36.9K | -52% | $0 |
| D | 2022-01-14 | 2022-01-06 | HOWL | Seidel-Dugan Cynthia | CSO | A - Grant | $0.00 | +79.5K | 79.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-12 | M | A | 15,532 | $4.77 | 164,888 | D | — | — | |
| 2 | Common | Common Stock | 2022-01-12 | M | A | 24,199 | $1.56 | 149,356 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2022-01-12 | M | D | 15,532 | $0.00 | 83,631 | D | $4.77 · — to 2030-12-07 | 15,532 Common Stock | (F3) The option was granted on December 8, 2020. The shares underlying the option vest over four years, with 25% of the shares vesting on the first anniversary of the grant date and 2.0833% of the shares vesting each month thereafter through December 8, 2024. |
| 4 | Derivative | Stock Option (right to buy) | 2022-01-06 | A | A | 79,516 | $0.00 | 79,516 | D | $11.55 · — to 2032-01-05 | 79,516 Common Stock | (F1) The option was granted on January 6, 2022 with a Vesting Commencement Date of January 1, 2022. The shares underlying the option vest over four years, with 25% of the shares vesting on the first anniversary of the Vesting Commencement Date and 2.0833% of the shares vesting each month thereafter through January 1, 2026. |
| 5 | Derivative | Stock Option (right to buy) | 2022-01-12 | M | D | 24,199 | $0.00 | 36,937 | D | $1.56 · — to 2030-05-19 | 24,199 Common Stock | (F2) The option was granted on May 20, 2020 with a Vesting Commencement Date of June 1, 2020. The shares underlying the option vest over four years, with 25% of the shares vesting on the first anniversary of the Vesting Commencement Date and 2.0833% of the shares vesting each month thereafter through June 1, 2024. |